Our findings showed that, in FOLFOX-treated MDR GC cells treated with Ubenimex, the expressions of Smac and total and cleaved caspase-3 were increased, but caspase-8 expression was not changed (Figures 3(g) and 3(h)). The gene discussed is CASP3; the disease is gastric cancer.